Professor David Newby graduated from the University of Southampton with a Bachelor of Science and Bachelor of Medicine degree in 1991. He has worked in Edinburgh for over 20 years and obtained Doctorates in Medicine, Philosophy and Science. Professor Newby is British Heart Foundation John Wheatley Chair of Cardiology at the University of Edinburgh, Director of the Wellcome Trust Clinical Research Facility, Director of the Clinical Research Imaging Centre, and a Consultant Interventional Cardiologist at Royal Infirmary of Edinburgh.
Professor Newby has major interests in experimental medicine and the advanced imaging of cardiovascular disease including coronary heart disease, aortic stenosis and heart failure. He currently holds a British Heart Foundation Programme Grant and a Wellcome Trust Senior Investigator Award to explore advanced imaging in coronary heart disease.
He has been involved in several multicentre trials and has played a major role in the conduct of the SALTIRE (Scottish Aortic stenosis Lipid lowering Trial, Impact on REgression) and 3CPO (Health Technology Assessment trial of non-invasive ventilation for acute cardiogenic pulmonary oedema) trials. He is Chief Investigator for the SCOT-HEART trial funded by the Chief Scientist Office, the National Institute for Health Research Efficacy and Mechanism Evaluation-funded MA3RS study and the Wellcome Trust-funded multi centre Prediction of Recurrent Events with 18F-Fluoride to Identify Ruptured and High-risk Coronary Artery Plaques in Patients with Myocardial Infarction (PRE18FFIR) trial.
For his research, Professor Newby was awarded the Goodall-Strickland Medal (British Cardiovascular Society), the Parmley Prize (American College of Cardiology) and British Medical Journal Research Awards 2014. In 2017, his team won the British Medical Journal Imaging Team of the Year Award. For his research, he and the British Heart Foundation Centre for Cardiovascular Science were awarded the Queen’s Anniversary Prize 2014-2016.